Detail

Neos Therapeutics : Xeris Pharmaceuticals, Inc. Appoints John P. Schmid to Board of Directors

Xeris Pharmaceuticals, Inc., a specialty biopharmaceutical company developing improved and differentiated injectable therapeutics for multiple indications including diabetes, announced the appointment of John P. Schmid to the Company's Board of Directors.